METASTATIC EWING SARCOMA
Clinical trials for METASTATIC EWING SARCOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC EWING SARCOMA trials appear
Sign up with your email to follow new studies for METASTATIC EWING SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cocktail of cancer drugs shows promise for Tough-to-Treat sarcoma
Disease control OngoingThis study tests whether adding three drugs (vincristine, irinotecan, and regorafenib) to standard chemotherapy can help people with Ewing sarcoma that has spread. About 437 participants will receive either the new combo or standard treatment. The goal is to see if the new approa…
Matched conditions: METASTATIC EWING SARCOMA
Phase: PHASE2, PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New hope for rare bone cancer: targeted drug added to chemo in major trial
Disease control OngoingThis study tests whether adding a targeted drug called ganitumab to standard chemotherapy helps people with newly diagnosed Ewing sarcoma that has spread. The trial includes 312 participants and aims to see if the combination improves survival without the cancer growing back. The…
Matched conditions: METASTATIC EWING SARCOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Experimental drug shows promise for Tough-to-Treat bone cancers
Disease control OngoingThis phase 2 trial tests the drug cabozantinib in 90 patients with osteosarcoma or Ewing sarcoma that has come back or spread. The drug works by blocking enzymes that help cancer cells grow and by cutting off the blood supply tumors need. Researchers are checking whether the canc…
Matched conditions: METASTATIC EWING SARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC